A comparison of hypolipidemic drugs in the prevention of an orotic acid fatty liver

Abstract
No abstract available
Funding Information
  • National Cancer Institute
  • U.S. Public Health Service
  • National Institute of Mental Health (5 ROl CA-01852-18)